Renal and Vascular Pathologies
Renal and Vascular Pathologies is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 35k research works in it since 1950. 10.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis and treatment of renal artery stenosis, including topics such as fibromuscular dysplasia, renovascular hypertension, renal function, stent placement, doppler ultrasonography, atherosclerotic renovascular disease, renal transplantation, oxidative stress, and angioplasty.
- Renal Artery Stenosis
- Fibromuscular Dysplasia
- Renovascular Hypertension
- Renal Function
- Stent Placement
- Doppler Ultrasonography
- Atherosclerotic Renovascular Disease
- Renal Transplantation
- Oxidative Stress
- Angioplasty
- Research works
- 35k fractional, since 1950
- In the world top 10%
- 3.7k per year above
- Top-10% rate
- 10.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Renal and Vascular Pathologies research?
By volume, the United States and China publish the most (1.2k and 524 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.2k works
- 2 China 524 works
- 3 India 345 works
- 4 Japan 261 works
- 5 United Kingdom 220 works
- 6 Italy 197 works
- 7 Germany 167 works
- 8 France 143 works
- 9 Türkiye 141 works
- 10 South Korea 134 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Renal and Vascular Pathologies research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Renal and Vascular Pathologies research, followed by Cleveland Clinic and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
- 2 Cleveland ClinicUnited States 19 works
- 3 All India Institute of Medical SciencesIndia 17 works
- 4 Mayo ClinicUnited States 17 works
- 5 Post Graduate Institute of Medical Education and ResearchIndia 16 works
- 6 Mayo Clinic in ArizonaUnited States 15 works
- 7 Johns Hopkins UniversityUnited States 15 works
- 8 Sağlık Bilimleri ÜniversitesiTürkiye 14 works
- 9 Ain Shams UniversityEgypt 14 works
- 10 Capital Medical UniversityChina 13 works
Who are the leading researchers in Renal and Vascular Pathologies?
The most-cited researchers publishing on Renal and Vascular Pathologies include Giuseppe Remuzzi, Norberto Perico and Tien Yin Wong.
- 1 Giuseppe Remuzzi Italy 8.1k citations
- 2 Norberto Perico Italy 6.1k citations
- 3 Tien Yin Wong Singapore 4.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Renal and Vascular Pathologies research done?
The largest centres of Renal and Vascular Pathologies research in 2022–2025 are Beijing (China), Seoul (South Korea), London (United Kingdom) and New York (United States).
Largest cities, 2022–2025
Where is the best place to study Renal and Vascular Pathologies?
Among universities, judged by research, Post Graduate Institute of Medical Education and Research, Medical University of Warsaw and Icahn School of Medicine at Mount Sinai score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Post Graduate Institute of Medical Education and ResearchIndia | 56.5 | 2.4% | 10.1× | 16 | +88.3% |
| 2 | Medical University of WarsawPoland | 48.2 | 0.4% | 11.3× | 12 | +74.4% |
| 3 | Icahn School of Medicine at Mount SinaiUnited States | 47.9 | 15.9% | 4.1× | 10 | +76.3% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 47.0 | 5.9% | 4.2× | 20 | +50.6% |
| 5 | Johns Hopkins UniversityUnited States | 46.4 | 8.1% | 2.9× | 15 | +83.2% |
| 6 | National and Kapodistrian University of AthensGreece | 41.2 | 13.5% | 3.5× | 9 | +69.9% |
| 7 | Sağlık Bilimleri ÜniversitesiTürkiye | 39.2 | 3.8% | 5.0× | 14 | — |
| 8 | Harvard UniversityUnited States | 38.9 | 14.0% | 1.6× | 10 | +45.4% |
| 9 | Capital Medical UniversityChina | 38.7 | 12.3% | 4.7× | 13 | -28.3% |
| 10 | University of TorontoCanada | 37.9 | 13.2% | 1.3× | 9 | +79.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Renal and Vascular Pathologies research growing?
Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Renal and Vascular Pathologies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.